Details for Patent: 12,521,396
Which drugs does patent 12,521,396 protect, and when does it expire?
Patent 12,521,396 protects KOMZIFTI and is included in one NDA.
This patent has twenty patent family members in twelve countries.
Summary for Patent: 12,521,396
| Title: | Pharmaceutical compositions comprising a MENIN inhibitor |
| Abstract: | Described herein are crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof, methods of making such forms, and pharmaceutical composition comprising such forms. |
| Inventor(s): | Jing Tao, Roger Paul BAKALE, Craig Michael Bowe, Dipanjan Sengupta, Patricia Andres, Chaoyi Deng |
| Assignee: | Keystone Pharma Consulting LLC , STA Pharmaceutical Hong Kong Ltd , Kura Oncology Inc |
| Application Number: | US18/827,538 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 12,521,396
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kura | KOMZIFTI | ziftomenib | CAPSULE;ORAL | 220305-001 | Nov 13, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,521,396
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2024292423 | ⤷ Start Trial | |||
| Australia | 2024292586 | ⤷ Start Trial | |||
| Chile | 2026000080 | ⤷ Start Trial | |||
| China | 121568692 | ⤷ Start Trial | |||
| China | 121620374 | ⤷ Start Trial | |||
| Colombia | 2026000207 | ⤷ Start Trial | |||
| European Patent Office | 4746867 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
